What is Brevium?
Brevium operates at the intersection of healthcare technology and practice management, offering an automated platform designed to re-engage overdue patients. By identifying and initiating contact with patients who have missed appointments or check-ups, Brevium helps medical practices optimize their schedules, improve patient compliance, and ultimately drive revenue growth. The software's ability to integrate seamlessly with existing practice management systems and provide customizable communication tools, alongside robust reporting, makes it a valuable asset for practices across various specialties seeking to enhance patient outcomes and demonstrate a clear return on investment.
How much funding has Brevium raised?
Brevium has raised a total of $1.4M across 2 funding rounds:
Debt
$350K
Private Equity
$1M
Debt (2020): $350K with participation from PPP
Private Equity (2025): $1M, investors not publicly disclosed
Key Investors in Brevium
PPP
Public-Private Partnership
What's next for Brevium?
With the recent major strategic investment and a substantial total funding history of $1.4M, Brevium is poised for accelerated growth and market expansion. The company's focus on patient reactivation software addresses a critical need within the healthcare sector for efficient patient retention and engagement strategies. This capital infusion is expected to fuel further development of its platform, enhance its sales and marketing efforts, and potentially explore new service offerings or integrations. Brevium's trajectory suggests a continued emphasis on leveraging technology to improve both patient care and the financial health of medical practices.
See full Brevium company page
